Chester County News and Community Website
WASHINGTON, D.C. — On Friday, the FDA approved Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) for treating chronic inflammatory demyelinating polyneuropathy (CIDP) in adults. This approval marks a significant development in …
FDA Approves New Treatment for Rare Nerve Disorder Read More
WASHINGTON, D.C. — In a major move to advance animal health and veterinary science, the Food and Drug Administration (FDA) announced a new grant opportunity on Thursday. The initiative aims …
FDA Launches Initiative to Boost Animal Health Research Read More
MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) has filed a new composition of matter patent with the U.S. Patent and Trademark Office. This patent covers novel crystalline forms of …
Annovis Bio Files Patent for New Crystal Form of Buntanetap Read More
SPRING HOUSE, PA — Johnson & Johnson (NYSE: JNJ) has submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for the approval of TREMFYA® …
Johnson & Johnson Seeks FDA Approval for TREMFYA in Treating Crohn’s Disease Read More
WASHINGTON, D.C. — The Food and Drug Administration (FDA) has approved the first generic version of the animal drug Temaril-P, offering a new option for pet owners and veterinarians. Trimeprazine …
FDA Approves First Generic Animal Drug for Itching and Cough Relief in Dogs Read More
WASHINGTON, D.C. — The FDA announced on Thursday that Cardinal Health is recalling kits containing unauthorized plastic syringes made by Jiangsu Shenli Medical Production Co Ltd. The recall involves Merit …
FDA Issues Recall for Unauthorized Chinese-Made Syringes Read More
WASHINGTON, D.C. — The Food and Drug Administration (FDA) has unveiled a new initiative aimed at reimagining homes as central hubs for health care. Announced Thursday, the Home as a …
FDA Launches Initiative to Transform Homes into Health Care Hubs Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) recently updated its advisory regarding illnesses linked to Diamond Shruumz-brand Chocolate Bars, Cones, and Gummies. As of June 17, 2024, …
FDA Warns Against Diamond Shruumz-brand Chocolate Bars, Cones, and Gummies Amid Illness Outbreak Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration has authorized the marketing of four menthol-flavored e-cigarette products by NJOY LLC. This decision marks the first time the FDA has …
FDA Authorizes Marketing of Four NJOY Menthol E-Cigarettes Read More
WASHINGTON, D.C. — This week, in a significant step for the medical world and hope for patients, the U.S. Food and Drug Administration expanded the approval of Elevidys, a gene …
FDA Broadens Approval of Elevidys Gene Therapy for Duchenne Muscular Dystrophy Patients Read More